Skip to main content

Dave Muoio

By Dave Muoio | 04:31 pm | May 01, 2018
Seattle-based 98point6 today announced the launch of its on-demand primary care platform.
By Dave Muoio | 02:35 pm | May 01, 2018
The National Institutes of Health announced today that national enrollment for its All of Us Research Program — an ambitious effort to collect demographic, health, genomic, and other data from at least 1 million Americans for use in healthcare research — will open on May 6 for those aged 18 years and older.
By Dave Muoio | 10:56 am | May 01, 2018
Health2047, a technology innovation enterprise focused on revamping healthcare, announced today a $27.
By Dave Muoio | 06:34 pm | April 30, 2018
Fitbit and Google have entered a partnership focused on better leveraging wearables and cloud-based technologies for digital health, the companies announced this morning.
By Dave Muoio | 12:59 pm | April 30, 2018
Two UnitedHealth Group senior executives have accepted leadership roles at Talkspace, the online therapy company announced in a recent statement.
By Dave Muoio | 04:20 pm | April 27, 2018
Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.
By Dave Muoio | 12:51 pm | April 27, 2018
Good omens for Good Doctor.
By Dave Muoio | 04:30 pm | April 26, 2018
Novartis announced yesterday that it has launched an app specifically designed for eye patients to participate in ophthalmic clinical trials.
By Dave Muoio | 02:53 pm | April 26, 2018
Researchers from the University of Wisconsin-Madison have detailed a wearable device that can better measure muscle-tendon tension during certain activities, such as walking or running.
By Dave Muoio | 05:07 pm | April 25, 2018
A study published yesterday in JAMA found that, compared to normal care, a home-based exercise program employing wearables and telephone coaching did not help patients with peripheral artery disease (PAD) improve their walking performance over a nine-month period.